Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 21641636

Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2011 Jun 18
First author
Maughan TS

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2011 Jun 18;377(9783):2060-2. doi: 10.1016/S0140-6736(11)60788-5.
    note
    Source null
    related pmid
    21641637
    relationship
    Comment in

Authors and identifiers

  1. name
    Maughan TS
    type
    Author
  2. name
    Adams RA
    type
    Author
  3. name
    Smith CG
    type
    Author
  4. name
    Meade AM
    type
    Author
  5. name
    Seymour MT
    type
    Author
  6. name
    Wilson RH
    type
    Author
  7. name
    Idziaszczyk S
    type
    Author
  8. name
    Harris R
    type
    Author
  9. name
    Fisher D
    type
    Author
  10. name
    Kenny SL
    type
    Author
  11. name
    Kay E
    type
    Author
  12. name
    Mitchell JK
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Maughan TS
    type
    Author
  2. name
    Adams RA
    type
    Author
  3. name
    Smith CG
    type
    Author
  4. name
    Meade AM
    type
    Author
  5. name
    Seymour MT
    type
    Author
  6. name
    Wilson RH
    type
    Author
  7. name
    Idziaszczyk S
    type
    Author
  8. name
    Harris R
    type
    Author
  9. name
    Fisher D
    type
    Author
  10. name
    Kenny SL
    type
    Author
  11. name
    Kay E
    type
    Author
  12. name
    Mitchell JK
    type
    Author
bibliography ids
  1. nci-bib-11b621f2da3a7341cc0a7fe8
book metadata
content sha256
e4d82b65b64d20e0d411a97a989f18709198c3944cee2bcd918e1d0741fe4d04
document type
citation
dois
  1. 10.1016/S0140-6736(11)60613-2
electronic publication date
display
2011 Jun 5
precision
day
year
2011
evidence scope
bibliographic_metadata_only
id
pubmed:21641636
immutable id
pubmed:21641636@e4d82b65b64d20e0d411a97a989f18709198c3944cee2bcd918e1d0741fe4d04
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
9783
name
Lancet (London, England)
nlm unique id
2985213R
pages
2103-14
volume
377
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2011 Jun 18;377(9783):2060-2. doi: 10.1016/S0140-6736(11)60788-5.
    note
    Source null
    related pmid
    21641637
    relationship
    Comment in
outcomes validated
false
pmid
21641636
provenance
batch id
a366a1bc8ed89d8d7ca5
provider
NCBI PubMed ESummary
record sha256
5df7f92161e8ce0b6a223d9beb6fe221d4b8561cd354b7a121db7ec591e08698
response sha256
c4fde29a469958f2f95ac1ef059ab1994169370e37d8293c0823efce81dabbb8
retrieved at
2026-09-09T23:46:40.540025+00:00
publication date
display
2011 Jun 18
precision
day
year
2011
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/21641636/
title
Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial.

Preserved source evidence · Independent clinical review pending · Not medical advice